share_log

EFFECT: Others

EFFECT: Others

EFFECT:其他
美股SEC公告 ·  04/22 18:06

Moomoo AI 已提取核心信息

Adial Pharmaceuticals, Inc. has achieved a significant milestone with the United States Securities and Exchange Commission (SEC) declaring its Form S-3 effective as of April 19, 2024, at 5:00 PM. This form is a registration statement that allows companies to issue various securities to the public. The effectiveness of this form indicates that Adial Pharmaceuticals has met all the necessary regulatory requirements to proceed with the issuance of securities.
Adial Pharmaceuticals, Inc. has achieved a significant milestone with the United States Securities and Exchange Commission (SEC) declaring its Form S-3 effective as of April 19, 2024, at 5:00 PM. This form is a registration statement that allows companies to issue various securities to the public. The effectiveness of this form indicates that Adial Pharmaceuticals has met all the necessary regulatory requirements to proceed with the issuance of securities.
Adial Pharmicals, Inc.取得了重要的里程碑,美国证券交易委员会(SEC)宣布其S-3表格自2024年4月19日下午5点起生效。该表格是一份注册声明,允许公司向公众发行各种证券。该表格的有效性表明,Adial Pharmicals已经满足了进行证券发行的所有必要监管要求。
Adial Pharmicals, Inc.取得了重要的里程碑,美国证券交易委员会(SEC)宣布其S-3表格自2024年4月19日下午5点起生效。该表格是一份注册声明,允许公司向公众发行各种证券。该表格的有效性表明,Adial Pharmicals已经满足了进行证券发行的所有必要监管要求。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息